Prof. dr. Gemma Vilahur
Sant Pau Barcelona, Spain
Dr. Vilahur is a Group Leader at the Research Institute of the Hospital de la Santa Creu i Sant Pau Barcelona. Previous appointments include a post-doctoral fellowship at Mount Sinai School of Medicine, New York (2004-2006), a Juan de la Cierva contract (2006-2009), subsequent Ramón y Cajal contract (2010-2015) and I3 accreditation.
She has authored 187 articles (PubMed) in the cardiovascular area (7100 citations, H-index=46), including original manuscripts, reviews and position/consensus articles and has contributed to over 35 book chapters. She is and has been an investigator and co-investigator of 50 research projects (National and European projects, either government or industry-funded). As a result of her research, she has received multiple Scientific Awards and Grants, including the L'Oréal-UNESCO Foundation for Women in Science Award (2012) and the Outstanding Achievement Award of the European Society of Cardiology for her scientific career (2019).
She is the past Chair of the Working Group on Thrombosis (2020-2022) of the European Society of Cardiology and is the current President of the European Society for Clinical Investigation (2023-2027). She has consolidated experience in coronary ischemic disease, from atherosclerosis and its cardiovascular risk factors to thrombosis and acute myocardial infarction, as well as in the identification of new therapeutic targets/strategies to prevent and treat myocardial infarction and subsequent development of heart failure. She is the author of 4 patents and has created 3 spin-offs.
Dr. Vilahur has contributed to multiple national and international continuing education courses/masters and is a member of the Editorial Board of prestigious journals in the cardiovascular area.